OR02 Endocrine Neoplasia: Tumorigenesis and Therapeutics

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Tumor Biology-Clinical/Translational
Thursday, March 5, 2015: 11:30 AM-1:00 PM
Room 6B (San Diego Convention Center)
**This session is NOT eligible for CME credit**

Chairs:
Ali Saeed Alzahrani, MD, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia and Rachel Schiff, PhD, Baylor College of Medicine, Houston, TX

Disclosures:
RS: Investigator, Astra Zeneca, Investigator, GlaxoSmithKline. Nothing to Disclose: ASA Disclosure Not Provided: SGW
11:30 AM
Sudheer Kumar Gara, Ph.D.1, Yonghong Wang, Ph.D.2, Dhaval Patel, M.D.1, Yi Liu-Chittenden, Ph.D.1, Myriem Boufraqech, Ph.D.1, Paul S Meltzer, MD, Ph.D.2 and Electron Kebebew, M.D.1, (1)Endocrine Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
(2)Genetics Branch, National Cancer Institute, NIH, Bethesda, MD
11:45 AM
Anastasia Melin1, Achim Starke, MD2, Aycan Akca, MD1, Peter Goretzki, MD1, Rajani Maharjan3, Per Hellman3 and Peyman Björklund3, (1)Visceral and Endocrine Surgery, Lukaskrankenhaus GmbH Neuss, Neuss, Germany
(2)Insulinoma and GEP Tumor Center Neuss-Düsseldorf, Lukaskrankenhaus GmbH Neuss, Neuss, Germany
(3)Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
12:00 PM
Gerard V Walls1, Mark Stevenson1, Ben Soukup2, Kate E Lines1, Paul T Christie1, Ashley B Grossman1, Herbert A Schmid3 and Rajesh V Thakker1, (1)Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom
(2)Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom
(3)Oncology Global Development, Novartis Pharmaceuticals, Basel, Switzerland
12:15 PM
Andrea Estrada, MD1, Aradhana Venkatesan2, Christopher L Wolfgang, MD, PhD3, Elliot K Fishman, MD3, Ihab Kamel, MD, PhD3, Syed Z Ali, MD3, Michael Goggins, MD3, Anirban Maitra, MBBS4, Lori Guthrie, RN5, Beth Brillante, RN5, Rachel I. Gafni, MD5, Anne Marie Lennon, MD, PhD3 and Michael T Collins, MD6, (1)Skeletal Clinical Studies Unit, CSDB, NIDCR/NICHD, NIH, Bethesda, MD
(2)National Institutes of Health, Bethesda, MD
(3)Johns Hopkins University School of Medicine
(4)MD Anderson
(5)National Institute of Dental and Craniofacial Research, National Institutes of Health
(6)Skeletal Clinical Studies Unit, NIDCR, NIH, Bethesda, MD
12:30 PM
Idit Dotan, MD, Department of Medicine, Division of Endocrinology and Metabolism, McGill Univerity Health Center, Lady Davis Institute for Medical Research-Jewish General Hospital, Montreal, QC, Canada, Elliot Jonathan Mitmaker, MD, MSc, FRCSC, FACS, Department of Surgery, McGill University Health Center, Montreal, QC, Canada, Philip Jonathan Rupert Roche, EngD, Lady Davis Institute for Medical Research-Jewish General Hospital, Montreal, QC, Canada, Lenore Katherine Beitel, PhD, Departments of Medicine and Human Genetics, McGill University, Lady Davis Institute for Medical Research-Jewish General Hospital, Montreal, QC, Canada, Michael Tamilia, MD, Department of Medicine, Division of Endocrinology and Metabolism, McGill University, Montreal, QC, Canada, Mark Anthony Trifiro, MD, Department of Medicine, Division of Endocrinology and Metabolism, The Jewish General Hospital, McGill University, Lady Davis Institute for Medical Research, Montreal, QC, Canada and Miltiadis Paliouras, PhD, Departments of Medicine and Experimental Medicine, Lady Davis Institute for Medical Research-Jewish General Hospital, McGill University, Montreal, QC, Canada
12:45 PM
Aleck Hercbergs1, Thangirala Sudha2, Murat Yalcin3, Hung-Yun Lin, PhD4, Mary Koeppe Luidens, MD5, Shaker A. Mousa, PhD6 and Paul J Davis, MD2, (1)Cleveland Clinic
(2)Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences
(3)Uludag University, Bursa, Turkey
(4)Taipei Medical University, Taiwan
(5)Division of Endocrinology, Albany Medical Center, Albany, NY
(6)Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY